Celebrating our Journey of Hope! Join us as we usher in PWSA | USA’s 50th Anniversary. Learn More

PWSA Blog

Ask Nurse Lynn GLP-1 Medications and PWS

Ask Nurse Lynn: GLP-1 Medications and PWS

Question:

Female, 32 years old, Deletion subtype

Is there any promise in trying Wegovy for weight loss? If so, what would be the side effects we would need to look out for?

Nurse Lynn’s Response:

There is interest in exploring GLP-1 medications like Wegovy for weight loss in individuals with PWS, but there are significant concerns. These medications primarily work by delaying gastric emptying, increasing satiety, and improving glycemic control. However, since delayed gastric emptying is already a common issue in PWS, their use could exacerbate constipation and increase the risk of severe complications like gastric necrosis or rupture.

Limited studies in individuals with PWS suggest these medications may improve glycemic control but do not appear to result in the same level of weight loss seen in the general population. Common side effects of GLP-1 medications include nausea, vomiting, diarrhea, and abdominal discomfort, which could be more pronounced in those with PWS.

Given these considerations, we anticipate additional studies with larger cohorts of PWS individuals are planned for 2025 to better understand the safety and efficacy of these medications in this population. Until then, it is crucial to consult with a healthcare provider familiar with PWS to weigh the potential risks and benefits for each individual.

Resources:

Below is a link to a published study for you to look at:

Liraglutide for Weight Management in Children and Adolescents With Prader–Willi Syndrome and Obesity | The Journal of Clinical Endocrinology & Metabolism | Oxford Academic

Do you have a question for Nurse Lynn? Submit your question here:

Share this!

Scroll to top